The University of Chicago Header Logo

Connection

Bryan Dickinson to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications Bryan Dickinson has written about Drug Evaluation, Preclinical.
Bryan Dickinson
Connection Strength
0.046
Drug Evaluation, Preclinical
  1. Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays. Methods. 2021 11; 195:57-71.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.